Development of an interfering peptide M1-20 with potent anti-cancer effects by targeting FOXM1

Disrupting protein–protein interactions (PPIs) has emerged as a promising strategy for cancer drug development. Interfering peptides disrupting PPIs can be rationally designed based on the structures of natural sequences mediating these interactions. Transcription factor FOXM1 overexpresses in multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bu, Huitong, Lan, Xianling, Cheng, Haojie, Pei, Chaozhu, Ouyang, Min, Chen, Yan, Huang, Xiaoqin, Yu, Li, Tan, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439915/
https://www.ncbi.nlm.nih.gov/pubmed/37598210
http://dx.doi.org/10.1038/s41419-023-06056-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439915/
https://www.ncbi.nlm.nih.gov/pubmed/37598210
http://dx.doi.org/10.1038/s41419-023-06056-9

Ejemplares similares